Analysts See $-0.05 EPS for Theratechnologies Inc. (TH); Teradyne Has 0.95 Sentiment

Friday, 30 March 2018

Analysts See $-0.05 EPS for Theratechnologies Inc. (TH); Teradyne Has 0.95 Sentiment

Teradyne, Inc. (NYSE:TER) Logo

Analysts expect Theratechnologies Inc. (TSE:TH) to report $-0.05 EPS on April, 5.They anticipate $0.02 EPS change or 66.67% from last quarter’s $-0.03 EPS. After having $-0.06 EPS previously, Theratechnologies Inc.’s analysts see -16.67% EPS growth. The stock increased 4.48% or $0.4 during the last trading session, reaching $9.33. About 160,604 shares traded. Theratechnologies Inc. (TSE:TH) has 0.00% since March 30, 2017 and is . It has underperformed by 11.55% the S&P500.

Teradyne Inc (TER) investors sentiment decreased to 0.95 in Q4 2017. It’s down -0.01, from 0.96 in 2017Q3. The ratio dropped, as 163 hedge funds started new and increased positions, while 172 trimmed and sold holdings in Teradyne Inc. The hedge funds in our database reported: 185.57 million shares, up from 185.56 million shares in 2017Q3. Also, the number of hedge funds holding Teradyne Inc in top ten positions decreased from 5 to 3 for a decrease of 2. Sold All: 27 Reduced: 145 Increased: 100 New Position: 63.

Among 2 analysts covering Theratechnologies Inc. (TSE:TH), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Theratechnologies Inc. has $10 highest and $2.50 lowest target. $8.50’s average target is -8.90% below currents $9.33 stock price. Theratechnologies Inc. had 6 analyst reports since February 25, 2016 according to SRatingsIntel. National Bank Canada downgraded it to “Outperform” rating and $4.25 target in Friday, November 11 report.

Theratechnologies Inc., specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and an enhanced life among HIV patients. The company has market cap of $699.54 million. The Company’s lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. It currently has negative earnings.

Since January 1, 0001, it had 0 insider buys, and 7 sales for $7.58 million activity.

Ratings analysis reveals 67% of Teradyne’s analysts are positive. Out of 3 Wall Street analysts rating Teradyne, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $25.0 while the high is $32.0. The stock’s average target of $28 is -38.74% below today’s ($45.71) share price. TER was included in 3 notes of analysts from October 28, 2016. Cowen & Co maintained the shares of TER in report on Friday, October 28 with “Outperform” rating. The stock of Teradyne, Inc. (NYSE:TER) earned “Market Perform” rating by BMO Capital Markets on Friday, October 28. The firm has “Buy” rating given on Friday, January 27 by Needham.

Teradyne, Inc. designs, develops, manufactures, sells, and supports automatic test equipment worldwide. The company has market cap of $8.93 billion. The Company’s Semiconductor Test segment offers semiconductor test services and products for wafer level and device package testing in automotive, industrial, communications, consumer, computer and electronic game, and other applications. It has a 35.71 P/E ratio. This segment offers FLEX test platform systems; Magnum platform that tests memory devices, such as flash memory and dynamic random access memory; J750 test system to address the highest volume semiconductor devices; and ETS platform for use by semiconductor manufacturers, and assembly and test subcontractors in the analog/mixed signal markets.

Analysts await Teradyne, Inc. (NYSE:TER) to report earnings on April, 25. They expect $0.42 earnings per share, down 4.55% or $0.02 from last year’s $0.44 per share. TER’s profit will be $82.08M for 27.21 P/E if the $0.42 EPS becomes a reality. After $0.46 actual earnings per share reported by Teradyne, Inc. for the previous quarter, Wall Street now forecasts -8.70% negative EPS growth.

The stock increased 1.96% or $0.88 during the last trading session, reaching $45.71. About 1.80 million shares traded. Teradyne, Inc. (TER) has risen 48.33% since March 30, 2017 and is uptrending. It has outperformed by 36.78% the S&P500.

Waterstone Capital Management L.P. holds 7.79% of its portfolio in Teradyne, Inc. for 255,900 shares. Winslow Asset Management Inc owns 322,881 shares or 2.49% of their US portfolio. Moreover, Telemark Asset Management Llc has 2.05% invested in the company for 250,000 shares. The Missouri-based Argent Capital Management Llc has invested 2.03% in the stock. Dixon Hubard Feinour & Brown Inc Va, a Virginia-based fund reported 134,676 shares.

Teradyne, Inc. (NYSE:TER) Institutional Positions Chart